Dolby Laboratories, Inc. Provides Earnings Guidance for the Second Quarter and Full Year of Fiscal 2013
January 29, 2013 at 04:08 pm
Share
Dolby Laboratories, Inc. provided earnings guidance for the second quarter and full year of fiscal 2013. For the year, the company now anticipates total revenue will range from $910 million to $950 million. The company now anticipates that operating expenses will be approximately $572 million on a GAAP basis and $500 million on a non-GAAP basis.
For the quarter, the company anticipates total revenue to range from $240 million to $250 million. Gross margin percentages are projected to be comparable to what they were in the first quarter of fiscal 2013. The company anticipates that operating expenses will be approximately $145 million on a GAAP basis and $127 million on a non-GAAP basis. The company expects diluted earnings per share to be between $0.53 and $0.60 on a GAAP basis and between $0.68 and $0.75 on a non-GAAP basis. The company estimates that its effective tax rate will range from 26% to 27%.
Dolby Laboratories, Inc. is engaged in designing and manufacturing of audio and imaging hardware and software products for the cinema, television, broadcast and entertainment industries. The Company's products are used in content creation, distribution and playback to enhance image and sound quality and improve transmission and playback. Its cinema imaging products include digital cinema servers used to load, store, decrypt, decode, watermark, and playback digital film files for presentation on digital cinema projectors and software used to encrypt, encode and package digital media files for distribution. Its cinema audio products include cinema processors, amplifiers and loudspeakers used to decode, render, and optimally play back digital cinema soundtracks, including those using Dolby Atmos. The Company's other products include three dimensional glasses and kits, broadcast hardware and software. Its technology includes Dolby Atmos, Dolby TrueHD, Dolby Vision and Dolby Digital Plus.
DOLBY LABORATORIES, INC. 
